Literature DB >> 18813075

Cultivated corneal endothelial transplantation in a primate: possible future clinical application in corneal endothelial regenerative medicine.

Noriko Koizumi1, Yuji Sakamoto, Naoki Okumura, Hideaki Tsuchiya, Ryuzo Torii, Leanne J Cooper, Yuriko Ban, Hidetoshi Tanioka, Shigeru Kinoshita.   

Abstract

PURPOSE: To review our attempt to devise a method of cultivated corneal endothelial transplantation using primates in which corneal endothelium, like that of humans, has low proliferative ability.
METHODS: Monkey corneal endothelial cells (MCECs) were cultivated, with subcultures grown on collagen type I carriers. The corneal endothelia of 6 eyes of 6 monkeys were scraped intensively, after which cultivated MCEC sheets were inserted into the anterior chamber of 4 eyes. As controls, a collagen sheet without MCECs was transplanted in 1 eye of a monkey, and a suspension of cultivated MCECs was injected into the anterior chamber of 1 eye of another monkey.
RESULTS: MCECs produced a confluent monolayer of closely attached hexagonal cells, which expressed both ZO-1 and Na-K adenosine triphosphatase. Early postoperative period MCEC sheets were attached to Descemet membrane, and corneal clarity was recovered. Six months after transplantation, MCEC-transplanted corneas remained clear, and closely attached hexagonal cells were observed. In 1 animal with longer observation, polygonal cells were observed by in vivo specular microscopy at a density of >2000 cells/mm2 and remained >1600 cells/mm2 for < or =2 years. Control eyes showed irreversible bullous keratopathy throughout the observation period.
CONCLUSIONS: Cultivated MCECs become attached to the transplanted eye and maintain a clear cornea < or =2 years postoperatively, suggesting that corneal endothelial cells of primates might have proliferative ability in vivo once they have been cultured and proliferated in vitro. Our monkey model constitutes an important step forward for regenerative medicine with possible future application in patients with corneal endothelial dysfunction.

Entities:  

Mesh:

Year:  2008        PMID: 18813075     DOI: 10.1097/ICO.0b013e31817f2298

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  25 in total

1.  Therapeutic efficiency of tissue-engineered human corneal endothelium transplants on rabbit primary corneal endotheliopathy.

Authors:  Ting-jun Fan; Jun Zhao; Xiu-zhong Hu; Xi-ya Ma; Wen-bo Zhang; Chao-zhong Yang
Journal:  J Zhejiang Univ Sci B       Date:  2011-06       Impact factor: 3.066

Review 2.  Corneal blindness and current major treatment concern-graft scarcity.

Authors:  Kah Hie Wong; Ka Wai Kam; Li Jia Chen; Alvin L Young
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

Review 3.  [Corneal cell therapy-an overview].

Authors:  M Fuest; G Hin-Fai Yam; G Swee-Lim Peh; P Walter; N Plange; J S Mehta
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

4.  Response of human corneal fibroblasts on silk film surface patterns.

Authors:  Eun Seok Gil; Sang-Hyug Park; Jeff Marchant; Fiorenzo Omenetto; David L Kaplan
Journal:  Macromol Biosci       Date:  2010-06-11       Impact factor: 4.979

5.  Regenerative Cell Therapy for Corneal Endothelium.

Authors:  Alena Bartakova; Noelia J Kunzevitzky; Jeffrey L Goldberg
Journal:  Curr Ophthalmol Rep       Date:  2014-09-01

Review 6.  Regenerative therapy for the Cornea.

Authors:  Ajay Kumar; Hongmin Yun; Martha L Funderburgh; Yiqin Du
Journal:  Prog Retin Eye Res       Date:  2021-09-14       Impact factor: 21.198

7.  Generation of novel monoclonal antibodies for the enrichment and characterization of human corneal endothelial cells (hCENC) necessary for the treatment of corneal endothelial blindness.

Authors:  Vanessa Ding; Angela Chin; Gary Peh; Jodhbir S Mehta; Andre Choo
Journal:  MAbs       Date:  2014       Impact factor: 5.857

8.  Comparison of proliferative capacity of genetically-engineered pig and human corneal endothelial cells.

Authors:  Minoru Fujita; Ruhina Mehra; Seung Eun Lee; Danny S Roh; Cassandra Long; James L Funderburgh; David L Ayares; David K C Cooper; Hidetaka Hara
Journal:  Ophthalmic Res       Date:  2012-12-18       Impact factor: 2.892

9.  Engineering of Human Corneal Endothelial Grafts.

Authors:  Ying-Ting Zhu; Sean Tighe; Shuang-Ling Chen; Thomas John; Winston Y Kao; Scheffer C G Tseng
Journal:  Curr Ophthalmol Rep       Date:  2015-06-27

10.  Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine.

Authors:  Naoki Okumura; EunDuck P Kay; Makiko Nakahara; Junji Hamuro; Shigeru Kinoshita; Noriko Koizumi
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.